| Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-CoA dehydrogenase deficiency. | |
| | |
MedLine Citation:
|
PMID: 10759157 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Glutaryl-CoA dehydrogenase deficiency is a neurometabolic disorder with a specific age- and region-dependent neuropathology. Between 6 and 18 mo of age, unspecific illnesses trigger acute encephalopathic crises resulting in acute striatal and cortical necrosis. We hypothesized that acute brain damage in glutaryl-CoA dehydrogenase deficiency is caused by the main pathologic metabolites 3-hydroxyglutaric and glutaric acids through an excitotoxic sequence. Therefore, we investigated the effect of 3-hydroxyglutaric acid and glutaric acid on primary neuronal cultures from chick embryo telencephalons and mixed neuronal and glial cell cultures from neonatal rat hippocampi. Exposure to glutaric acid and 3-hydroxyglutaric acid decreased cell viability in a concentration- and time-dependent fashion. This neurotoxic effect could be totally prevented by preincubation with an N-methyl-D-aspartate receptor subunit 2B (NR2B)-specific antagonist, NR2B antibodies, and an unspecific N-methyl-D-aspartate receptor blocker and was partially blocked with an NR2A-specific antagonist but not with NR2A antibodies or alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor and metabotropic glutamate receptor antagonists. Furthermore, metabolite toxicity increased in parallel with the increasing expression of the NR2B subunit on cultured neurons from second to sixth day in vitro. We conclude from these results that 3-hydroxyglutaric acid and glutaric acid act as false neurotransmitters, in particular through NR1/2B, and that the extent of induced neurotoxicity is dependent on the temporal and spatial expression of NR1/2B in the CNS during maturation. Beyond favorable implications for treatment and long-term prognosis, glutaryl-CoA dehydrogenase deficiency is the first neurologic disease in which specific neuropathology could be experimentally linked to ontogenetic expression of a particular neurotransmitter receptor subtype. |
| | |
Authors:
|
S Kölker; B Ahlemeyer; J Krieglstein; G F Hoffmann |
Related Documents
:
|
23007447 - Overexpression of rice lrk1 restricts internode elongation by down-regulating osko2. 23258597 - Use of electrophysiological methods in the study of recombinant and native neuronal lig... 7690067 - Aspartate and glutamate mediate excitatory synaptic transmission in area ca1 of the hip... 22962967 - Nanoscale graphene oxide (ngo) as artificial receptors: implications for biomolecular i... 2981667 - Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localiza... 9400027 - Chronic administration of a glycine partial agonist alters the expression of n-methyl-d... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Pediatric research Volume: 47 ISSN: 0031-3998 ISO Abbreviation: Pediatr. Res. Publication Date: 2000 Apr |
Date Detail:
|
Created Date: 2000-06-01 Completed Date: 2000-06-01 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0100714 Medline TA: Pediatr Res Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 495-503 Citation Subset: IM |
Affiliation:
|
Department of Neuropediatrics and Metabolic Diseases, University of Marburg, Federal Republic of Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antibodies / pharmacology Brain Diseases, Metabolic, Inborn / enzymology*, pathology Cells, Cultured Chick Embryo Dizocilpine Maleate / pharmacology Glutarates / antagonists & inhibitors, toxicity* Glutaryl-CoA Dehydrogenase Neurons / drug effects* Oxidoreductases / deficiency* Oxidoreductases Acting on CH-CH Group Donors* Piperidines / pharmacology Rats |
| Chemical | |
Reg. No./Substance:
|
0/3-hydroxyglutaric acid; 0/Antibodies; 0/Glutarates; 0/Piperidines; 110-94-1/glutaric acid; 23210-56-2/ifenprodil; 77086-22-7/Dizocilpine Maleate; EC 1.-/Oxidoreductases; EC 1.3.-/Oxidoreductases Acting on CH-CH Group Donors; EC 1.3.99.7/Glutaryl-CoA Dehydrogenase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Detection by mass spectrometry of highly increased amount of S-sulfonated transthyretin in serum fro...
Next Document: Failure of the loop diuretic torasemide to improve renal function of hypoxemic vasomotor nephropathy...